They found that knockdown of NEAT1 modulates OGD/R injury in CHME5 cells via the miR-374a-5p/NFAT5 axis, thereby inducing microglia migration from M1 to M2 and suppressing inflammatory responses, making it a potential target for stroke therapy (249). The gene discussed is NEAT1; the disease is Stroke.